Breast cancer with pocitive axillary node treated by neoadjuvant chemotherapy
Conditions
Interventions
sentinel lymph node biopsy
Sponsors
Department of Breast and Endocrine Surgery, Kumamoto University
Department of Breast and Endocrine Surgery Nagoya City University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. The case signed informed consent of the patients for the registration 2. The case confirmed by cytological or pathological diagnosis in primary lesion 3. The case comfirmed by cytological or pathological diagnosis in axillary lymph node before treatment 4. The case who treated by neoadjuvant chemotherapy 5. The case who will be prepared by radica operation including axilary dissection under general anesthesia 6. The case with a satisfactory function of a heart/liver/kidney/bone marrow and to satisfy the next condition Hb: more than 8g/dl AST(GOT), ALT(GPT): Less than 2.5 times of the normal value upper limit of the institution
Exclusion criteria
Exclusion criteria: 1. The case with active other malignancies 2. The case with past history of drug allergy or hypersensitivity 3. The case during pregnancy or lactation 4. The case judged inappropriate by physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse event, predictive factor | — |
Countries
Japan
Contacts
Public ContactAyako Okabe
Faculty of Life Sciences, Kumamoto University Department of Breast and Endocrine Surgery
Outcome results
None listed